Biden Administration: Vaccine Rollout Not Impacted

The transcript discusses the availability of COVID-19 vaccines in the U.S., highlighting that there is sufficient supply of Pfizer and Moderna vaccines to maintain a vaccination rate of 3 million shots per day. This supports the goal of administering 200 million shots by the President's 100th day in office. Additionally, it covers the FDA and CDC's recommendation to pause the Johnson & Johnson vaccine due to rare blood clot cases, with six incidents reported out of nearly 7 million doses administered.

What is the current daily vaccination rate in the US?

• 4 million shots per day

• 1 million shots per day

• 2 million shots per day

• 3 million shots per day

Which vaccines are mentioned as having enough supply to maintain the vaccination pace?

• Johnson & Johnson and Moderna

• Pfizer and AstraZeneca

• Moderna and AstraZeneca

• Pfizer and Moderna

What is the president's target for the number of shots by his 100th day in office?

• 150 million shots

• 250 million shots

• 200 million shots

• 100 million shots

Why did the FDA and CDC recommend pausing the Johnson & Johnson vaccine?

• Due to low efficacy

• Due to rare blood clot reports

• Due to manufacturing issues

• Due to high demand

How many cases of blood clots were reported after administering the Johnson & Johnson vaccine?

• 6 cases

• 12 cases

• 9 cases

• 3 cases